Sipeki, S <br/><br/>
Protein kinase C decreases the hepatocyte growth factor-induced activation of Erk1/Erk2 MAP kinases.  [electronic resource] 

 -  Cellular signalling  Aug 2000 
 - 549-55 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0898-6568 
<br/><br/><label>Standard No.: </label>10.1016/s0898-6568(00)00105-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Enzyme Activation<br/>Gene Expression Regulation<br/>Hepatocyte Growth Factor--pharmacology<br/>Humans<br/>MAP Kinase Signaling System<br/>Mitogen-Activated Protein Kinase 1--metabolism<br/>Mitogen-Activated Protein Kinase 3<br/>Mitogen-Activated Protein Kinases--metabolism<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Phosphorylation<br/>Protein Kinase C--drug effects<br/>Tetradecanoylphorbol Acetate--pharmacology<br/>Tumor Cells, Cultured